In This Issue: Translational Opportunities for Antibodies: Therapeutics, Biomarkers, and Novel Targets

Int Rev Immunol. 2016 Jul 3;35(4):291-293. doi: 10.1080/08830185.2016.1236584.

Authors

Adrian Bot¹, Himanshu Kumar²

Affiliations

¹ a Editor-in-Chief, International Reviews of Immunology and Vice President, Translational Sciences , Kite Pharma Inc., Santa Monica , CA , USA.
² b Associate Editor-in-Chief, International Reviews of Immunology, Associate Professor, Laboratory of Immunology and Infectious Disease Biology, Indian Institute of Science Education and Research (IISER) , Bhopal , India.

PMID: 27797621
DOI: 10.1080/08830185.2016.1236584

No abstract available

Publication types

Editorial

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Biomarkers / analysis*
Humans
Immunotherapy / methods*

Substances

Antibodies, Monoclonal
Biomarkers